unterfreiemhimmel.net
S-Target SG100 » Unter freiem Himmel
http://unterfreiemhimmel.net/en/portfolio/s-target-sg100
Film, Animation and interactive Installations. March 4th, 2013. The Start-up company S-TARget. Is developing novel therapeutic vaccines to cure and prevent allergic diseases. We created an animation to demonstrate the possible capabilities of their future medications. EU LEADER-Region Oststeirisches Kernland. EU LEADER-Region Oststeirisches Kernland. Die Natur wird es ihnen danken. Die Natur wird es ihnen danken. Unter freiem Himmel OG. Video- and multimedia production. Regional and commercial court:.
solveresearch.com
Partners/customers | SOLVE Research and Consultancy AB
http://www.solveresearch.com/about-us/partners
We offer world leading, premium, custom solutions for comprehensive characterization, development and application of next generation and complex materials. We incorporate state-of-the art separation techniques like field-flow fractionation. Into our customized materials characterization strategies to provide world class solutions. We are excited to work with you. Contact us today and tell us what challenges you face and we will find a way to SOLVE them. 2016 SOLVE Research and Consultancy AB |.
allergopharma.com
Allergopharma and S-TARget therapeutics conclude licensing agreement
https://www.allergopharma.com/news/details/news/allergopharma-and-s-target-therapeutics-conclude-licensing-agreement
Reporting of Adverse Drug Reactions. Allergopharma and S-TARget therapeutics conclude licensing agreement. Objective is new generation of therapeutics for allergy treatment. Reinbek, Germany, September 2, 2014 Allergopharma, the Merck Business Unit Allergy, and S-TARget therapeutics (S-TARget), an Austrian biotechnology company which develops therapeutic preparations for all forms of allergies, have signed an exclusive licensing agreement. The main focus of this cooperation is the use of. Christof Langer...
systemsbiology.at
Systems Biology - Partners
http://www.systemsbiology.at/content/show/id/3
Succesfull collaborations in the past:.